Literature DB >> 1645377

Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema.

W Seeger1, F Grimminger, M Barden, G Becker, J Lohmeyer, D Heinrich, H G Lasch.   

Abstract

Leukotriene (LT) generation has been implicated in the pathogenesis of the acute respiratory distress syndrome, ARDS. In the present study, we analysed broncho-alveolar lavage fluids of patients on mechanical ventilation because of ARDS (17 samples taken from 9 patients) or because of cardiogenic edema (8 samples taken from 6 patients) and of healthy volunteers (10 samples from different donors). LTs were separated as methylated and non-methylated compounds using different HPLC procedures, and were identified by chromatographic mobility, on-line UV-spectrum analysis and post HPLC immunoreactivity. In the lavage samples of the healthy volunteers and the patients with cardiogenic edema, no LTs were detected by these techniques (detection limit congruent to 0.1-0.2 ng/ml lavage fluid). By contrast, in 15 out of 17 samples from patients with ARDS LTB4 or its metabolites 20-OH-LTB4 and 20-COOH-LTB4 were detected. The endproduct of omega-oxidation, 20-COOH-LTB4, represented the quantitatively predominant compound, detected in the range of 0.3-2.6 ng/ml perfusate. We conclude that the chemotactic agent LTB4 may be involved in the amplification of inflammatory events encountered in ARDS, and that the oxidized metabolites of LTB4 are particularly suitable for monitoring lung leukotriene generation under conditions of neutrophil efflux and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645377     DOI: 10.1007/bf01708400

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  33 in total

1.  Leukotrienes and ARDS.

Authors:  W Seeger; F Grimminger
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 2.  Species variations in the pulmonary responses to arachidonic acid metabolites.

Authors:  N F Voelkel
Journal:  Prostaglandins       Date:  1985-05

Review 3.  Pulmonary microvascular effects of arachidonic acid metabolites and their role in lung vascular injury.

Authors:  A B Malik; M B Perlman; J A Cooper; T Noonan; R Bizios
Journal:  Fed Proc       Date:  1985-01

4.  High yield enzymatic conversion of intravascular leukotriene A4 in blood-free perfused lungs.

Authors:  F Grimminger; G Becker; W Seeger
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

5.  Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS.

Authors:  A H Stephenson; A J Lonigro; T M Hyers; R O Webster; A A Fowler
Journal:  Am Rev Respir Dis       Date:  1988-09

6.  Detection of leukotrienes B4, C4 and of their isomers in arterial, mixed venous blood and bronchoalveolar lavage fluid from ARDS patients.

Authors:  M Antonelli; M Bufi; R A De Blasi; G Crimi; G Conti; C Mattia; G Vivino; L Lenti; D Lombardi; A Dotta
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 7.  Bronchoalveolar lavage.

Authors:  H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1987-01

8.  Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors.

Authors:  S C Afford; R A Stockley; J A Kramps; J H Dijkman; D Burnett
Journal:  Anal Biochem       Date:  1985-11-15       Impact factor: 3.365

Review 9.  Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease.

Authors:  R P Daniele; J A Elias; P E Epstein; M D Rossman
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

10.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

View more
  6 in total

Review 1.  Pulmonary diseases other than asthma as potential targets for antileukotriene therapy.

Authors:  M Peters-Golden
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.

Authors:  E R Pettipher; E D Salter; R Breslow; L Raycroft; H J Showell
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

3.  Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity.

Authors:  D M Guidot; M J Repine; J Y Westcott; J E Repine
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

4.  Ferritin and desferrioxamine attenuate xanthine oxidase-dependent leak in isolated perfused rat lungs.

Authors:  Brooks M Hybertson; Kevin G Connelly; Raquel T Buser; John E Repine
Journal:  Inflammation       Date:  2002-08       Impact factor: 4.092

5.  Leukotriene A4 hydrolase in human bronchoalveolar lavage fluid.

Authors:  D A Munafo; K Shindo; J R Baker; T D Bigby
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

6.  Inhibition of leukotriene B4 receptor 1 attenuates lipopolysaccharide-induced cardiac dysfunction: role of AMPK-regulated mitochondrial function.

Authors:  Meng Sun; Rui Wang; Qinghua Han
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.